Global Dna Sequencing Services Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product Type;

Maxam – Gilbert sequencing, Chain-termination methods, Dye-terminator sequencing, Automation and sample preparation, Large-scale Sequencing, New Sequencing Methods, High Throughput Sequencing, Parallel Signature Sequencing (MPSS), Polony Sequencing, Pyrosequencing, Illumina (Solexa) Sequencing, SOLiD Sequencing, and Others.

By Application;

Hospitals, Diagnostic Centers, Biotechnology and Pharmaceutical Industry, Academic Research Institutes, and Other Application Areas.

By End Use;

Automotive, Chemical, Agriculture, Oil and Gas, Research and Development, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn453278382 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Dna Sequencing Services Market (USD Million), 2021 - 2031

In the year 2024, the Global Dna Sequencing Services Market was valued at USD 12,402.11 million. The size of this market is expected to increase to USD 39,506.59 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 18.0%.

The Global DNA Sequencing Services Market is a rapidly evolving sector within the broader field of genomics, offering extensive capabilities for analyzing genetic material. DNA sequencing involves determining the precise order of nucleotides within a DNA molecule, providing critical insights into genetic variations and mutations. These insights are essential for a wide range of applications, including biomedical research, clinical diagnostics, personalized medicine, and agricultural biotechnology. The market has witnessed substantial growth due to technological advancements that have made sequencing faster, more accurate, and more cost-effective.

Key drivers propelling the market's growth include the increasing demand for personalized medicine, advancements in sequencing technologies, and the expanding scope of genomic research. Personalized medicine, which tailors medical treatment to the individual characteristics of each patient, relies heavily on genomic data. This demand has spurred innovations in sequencing technologies, making them more accessible to researchers and clinicians alike. Additionally, the integration of bioinformatics and data analysis tools has enhanced the ability to interpret complex genomic data, further boosting the market's expansion.

Despite its growth prospects, the Global DNA Sequencing Services Market faces several challenges, including high initial costs, data privacy concerns, and regulatory complexities. The initial investment required for sequencing infrastructure can be substantial, posing a barrier for smaller research institutions and companies. Moreover, the handling and storage of genetic data raise significant privacy and ethical issues, necessitating robust regulatory frameworks to ensure data protection. As the market continues to evolve, addressing these challenges will be crucial for sustaining its growth and maximizing its potential benefits across various sectors.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Application
    3. Market Snapshot, By End Use
    4. Market Snapshot, By Region
  4. Global Dna Sequencing Services Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Technological advancements increasing.
        2. Cost reduction strategies.
        3. Growing research applications.
        4. Personalized medicine demand.
        5. Data analysis improvements.
      2. Restraints
        1. High initial costs.
        2. Data privacy concerns.
        3. Skilled workforce shortage.
        4. Ethical issues emerging.
        5. Regulatory hurdles challenging.
      3. Opportunities
        1. Emerging market penetration.
        2. New clinical applications.
        3. Innovative partnerships forming.
        4. Advancements in bioinformatics.
        5. Expansion in diagnostics.
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Dna Sequencing Services Market, By Product Type, 2021 - 2031 (USD Million)
      1. Maxam – Gilbert sequencing
      2. Chain-termination methods
      3. Dye-terminator sequencing
      4. Automation & sample preparation
      5. Large-scale Sequencing
      6. New Sequencing Methods
      7. High Throughput Sequencing
      8. Parallel Signature Sequencing (MPSS)
      9. Polony Sequencing
      10. Pyrosequencing
      11. Illumina (Solexa) Sequencing
      12. SOLiD Sequencing
      13. Others.
    2. Global Dna Sequencing Services Market, By Application, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Diagnostic Centers
      3. Biotechnology and Pharmaceutical Industry
      4. Academic Research Institutes
      5. Other Application Areas
    3. Global Dna Sequencing Services Market, By End Use, 2021 - 2031 (USD Million)
      1. Automotive
      2. Chemical
      3. Agriculture
      4. Oil & Gas
      5. Research & Development
      6. Others.
    4. Global Dna Sequencing Services Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Illumina, Inc.
      2. Thermo Fisher Scientific Inc.
      3. BGI Group
      4. PerkinElmer, Inc.
      5. Eurofins Scientific
      6. Agilent Technologies, Inc.
      7. Pacific Biosciences of California, Inc.
      8. Oxford Nanopore Technologies Ltd.
      9. QIAGEN N.V.
      10. Roche Sequencing and Life Science.
  7. Analyst Views
  8. Future Outlook of the Market